Strattera
Strattera
- Strattera (atomoxetine) is a prescription-only medicine in the UK and most countries, but it is commonly purchased through licensed pharmacies and online services with a valid prescription. It is not a controlled substance.
- Strattera is used for the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults. It is a non-stimulant selective noradrenaline reuptake inhibitor, which increases noradrenaline levels in the brain to help improve attention and reduce impulsivity and hyperactivity.
- The usual dose for adults is 40 mg once daily, increased to a target of about 80 mg daily, with a maximum of 100 mg per day. In children and adolescents, treatment often starts at about 0.5 mg/kg/day and may be increased after at least 3 days to around 1.2 mg/kg/day, without exceeding 1.4 mg/kg/day or 100 mg daily, whichever is lower.
- Strattera is taken by mouth as capsules.
- It may begin to have some effect within 1–2 weeks, but the full benefit often takes several weeks, sometimes 4–6 weeks or longer.
- The duration of action lasts about 24 hours, so it is usually taken once daily; in some cases it may be split into two doses.
- Alcohol should be avoided or limited, as it may worsen dizziness, drowsiness and other side effects.
- The most common side effects include decreased appetite, dry mouth, nausea, stomach upset, fatigue, dizziness, headache and sleep disturbances.
- Would you like to try Strattera without a prescription?
Basic Strattera Information
- INN (International Nonproprietary Name): Atomoxetine
- Brand Names Available In United Kingdom: Strattera
- ATC Code: N06BA09
- Forms & Dosages: Capsule strengths include 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, and 100 mg.
- Manufacturers In United Kingdom: Eli Lilly is the original producer and principal global supplier, with multiple generic manufacturers available after patent expiry.
- Registration Status In United Kingdom: EMA authorised as Strattera and available in most countries globally for ADHD therapy in children aged 6 years and over, adolescents, and adults.
- OTC / Rx Classification: Prescription only (Rx).
- Use-Cases: Mainly indicated for ADHD treatment when stimulants are contraindicated, ineffective, or cause unwanted side effects.
Latest Research Highlights: UK And EU Evidence, 2022–2025
Is Strattera still a sensible option when people in the UK want something that is not a stimulant?
The short answer is yes, especially when methylphenidate or lisdexamfetamine are not suitable, or when there is concern about misuse, palpitations, or other stimulant-related problems.
Recent UK and EU real-world data continue to support atomoxetine for ADHD as a non-stimulant ADHD medication UK clinicians may reach for when routine stimulant treatment is not a good fit.
The main story is not dramatic cure rates, but steady symptom reduction, better daily functioning for some patients, and a safety profile that needs monitoring rather than panic.
| Study Type | Population | Outcome | Safety Signal |
|---|---|---|---|
| Real-world routine practice studies | Children, adolescents, and adults treated for ADHD | Improved attention, impulsivity, and day-to-day functioning in a proportion of patients | Common adverse effects plus ongoing psychiatric monitoring, especially early in treatment |
| Observational adherence and persistence reviews | Patients prescribed atomoxetine in routine care | Long-term treatment often continued when benefit was gradual and tolerability acceptable | Discontinuation often linked to delayed onset, side effects, or insufficient response |
| Regulatory safety monitoring | Children and adolescents in the MHRA and EMA setting | Benefit judged after a minimum 4–6 week trial, with longer-term review as needed | Boxed warning for suicidal ideation in young people and cardiovascular monitoring advice |
What matters in NHS practice is not just whether the medicine works in a trial.
It is whether a patient can stay on it, cope with the slower start, and get enough improvement to make school, work, or home life easier.
That is where atomoxetine often earns its place.
It is not a controlled substance, and it is prescription only, which makes it a common discussion point in NHS prescribing decisions when there are concerns about misuse or stimulant intolerance.
MHRA safety thinking also stays central in the UK.
Psychiatric monitoring is advised, particularly during the first months, and the boxed warning about suicidal ideation in children and adolescents remains important when families are weighing risk against benefit.
For response, a minimum trial period of 4 to 6 weeks is usually needed before benefit is properly judged, although some people need longer for a fair assessment.
Clinical Effectiveness In The United Kingdom: What Patients And Clinicians Report
Does Strattera feel different from stimulant ADHD medicine?
Many UK patients say yes, and that is often exactly why it is chosen.
Atomoxetine for ADHD tends to come up in NHS settings when people want a non-stimulant approach, or when stimulants have caused problems with appetite, sleep, heart rate, or misuse concerns.
Patients often report gradual improvements in attention, less impulsive behaviour, and better ability to get through everyday tasks without the sharper “on/off” feeling some stimulants can cause.
The trade-off is slower onset.
That slower start affects adherence because some people expect an immediate change and stop too early.
In practice, pharmacists and prescribers usually have to explain that atomoxetine is assessed over weeks, not days.
| Age Group | What People Often Notice | Common Limitation |
|---|---|---|
| Children | Better attention and less disruption at school | Families may expect faster change and need counselling on the 4–6 week minimum assessment period |
| Adolescents | Improved organisation and reduced impulsivity | Appetite change, mood swings, or reluctance to stay with a slower-acting medicine |
| Adults | Better daily functioning, work focus, and routine management | Need for dose titration and patience before benefit is clear |
Adults in the UK are commonly started at 40 mg daily, with a target of about 80 mg daily and a maximum of 100 mg daily.
That fits well with routine NHS-style review, where response and side effects are checked before moving up.
In long-term treatment, the aim is not perfection.
It is enough symptom control to make daily life more manageable, with tolerable side effects and realistic expectations.
Patients using NHS patient portals or repeat prescription systems often want a quick explanation from the pharmacist when their capsule strength changes or when they notice the effect building slowly.
That kind of practical advice matters as much as the prescription itself.
Indications And Expanded Uses: Licensed And Off-Label Realities
What is atomoxetine actually licensed for in the UK?
Its MHRA-approved indication is ADHD in children aged 6 years and over, adolescents, and adults.
It is prescription only, and that point matters because online searches such as “Strattera without prescription” are not legally permitted in the UK.
When clinicians choose it, they are usually thinking about standard ADHD care rather than a broad list of unrelated uses.
- Licensed
- A medicine used within its approved indication, age range, and dosing framework.
- Off-label
- Use outside the approved wording, which may happen in specialist practice but needs careful justification.
- NHS
- Prescribing or supply through UK health services, usually with structured review and repeat prescription systems.
- Private prescribing
- Prescribing outside NHS routes, often after specialist assessment and with separate payment arrangements.
Atomoxetine is especially useful when stimulants are contraindicated, ineffective, or poorly tolerated.
It is also attractive in patients where misuse risk is a concern, because it is not a controlled substance and does not have the same euphoric profile as stimulant medicines.
That said, the absence of controlled-drug status does not mean it is casual to prescribe.
The same safety checks still apply, especially around mood, blood pressure, and heart rate.
Composition And Brand Landscape: Strattera, Generic Atomoxetine, And Packaging
Why does packaging matter so much with ADHD medicine?
Because small differences can affect adherence, confidence, and even the risk of taking the wrong strength.
Atomoxetine is the INN, and Strattera is the best-known brand name in the UK, EU, and globally.
After patent expiry, generic atomoxetine is widely available, and pharmacies may dispense different suppliers through NHS electronic prescriptions.
Patients using Boots, LloydsPharmacy, or Superdrug may see changes in capsule appearance depending on stock and manufacturer.
That can be unsettling unless it is explained well.
| Strength | Capsule Colour / Imprint | Packaging Note |
|---|---|---|
| 10 mg | Yellow, marked “Lilly” | Blister packs |
| 18 mg | Blue | Blister packs |
| 25 mg | Red/brown | Blister packs |
| 40 mg | Blue/white | Blister packs |
| 60 mg | Yellow/capsule | Blister packs |
| 80 mg | Brown | Blister packs |
| 100 mg | Blue/white | Blister packs |
Eli Lilly is the original producer and principal global supplier.
In the UK, the active ingredient may be supplied under the brand or as a generic atomoxetine ADHD product, but the medicine and its dose still need to be checked carefully each time.
That is especially true when the prescription changes from Strattera capsules to a generic equivalent.
Contraindications And Special Precautions: Who Needs Extra Caution
Could someone with heart problems or glaucoma take atomoxetine?
Not always.
There are clear situations where it should not be used, and others where it needs close monitoring.
The boxed warning for suicidal ideation in children and adolescents is also part of safe prescribing, particularly early in treatment.
| Issue | Concern | Action / Monitoring |
|---|---|---|
| Hypersensitivity | Allergic reaction to atomoxetine or a capsule component | Do not use |
| Narrow-angle glaucoma | Risk of worsening eye pressure | Do not use |
| MAOI use within 14 days | Serious interaction risk | Avoid combination |
| Severe cardiovascular disorder | Severe hypertension or tachyarrhythmia risk | Do not use |
| Hypertension or tachycardia | Blood pressure or pulse may rise | Monitor closely |
| Seizure history | May complicate treatment | Monitor closely |
| Psychiatric comorbidity | Depression or suicidal ideation risk in young patients | Monitor closely, especially early on |
| Hepatic impairment | Drug handling may change | Reduce dose and monitor |
Driving advice is a common UK question.
People usually want to know if they can keep commuting, working, or getting through school runs while starting treatment.
The practical answer is to be cautious if dizziness, fatigue, or sleep disturbance affects concentration.
Alcohol can make side effects like drowsiness or palpitations more noticeable in some people, so tolerance varies and it is sensible to keep it modest at first.
Liver impairment matters because dose reduction is needed in moderate and severe cases.
Kidney impairment usually does not require an adjustment if mild or moderate, but caution is still sensible if disease is severe.
Dosage Guidelines: NHS-Style Titration And Special Populations
How is atomoxetine usually started in UK practice?
For children and adolescents, treatment begins at about 0.5 mg/kg/day and is increased after a minimum of 3 days to around 1.2 mg/kg/day, without exceeding 1.4 mg/kg/day or 100 mg, whichever is lower.
Adults usually start at 40 mg daily, move to a target of about 80 mg daily, and do not go above 100 mg daily.
The medicine can be taken once daily in the morning, or split into morning and late afternoon or evening doses if the prescriber advises it.
- Start with the prescribed dose and do not change it yourself.
- Allow time for gradual benefit, because response is often reviewed after 4 to 6 weeks.
- Watch for side effects such as appetite loss, dry mouth, nausea, fatigue, or sleep disturbance.
- Report troublesome mood changes, palpitations, or rising blood pressure promptly.
- Keep follow-up appointments so the dose can be adjusted safely.
| Population | Usual Dose Note | Practical Comment |
|---|---|---|
| Children under 6 years | Not studied | Use not recommended |
| Adults | 40 mg daily to 80 mg daily | Maximum 100 mg daily |
| Elderly | Data limited | Caution advised |
| Moderate liver impairment | Start at half usual dose | Monitor closely |
| Severe liver impairment | Start at one-quarter dose | Monitor closely |
| Mild or moderate kidney impairment | No adjustment usually needed | Caution if severe |
Prescriptions should always follow NHS or private specialist directions rather than online advice.
That is especially important when a patient is comparing Strattera 40 mg, Strattera 60 mg, or Strattera 80 mg options and wondering which one is “best”.
The answer is the one that matches their current plan.
Interactions Overview: Medicines, Food, Drink, And MHRA Reporting
Can atomoxetine be taken with other medicines and a normal cup of tea or coffee?
Sometimes yes, but interactions matter.
People in the UK often ask about caffeine because they already rely on tea, coffee, or energy drinks to get through the day.
With atomoxetine, tolerance varies, and some side effects such as palpitations or sleep disturbance can be more noticeable if caffeine intake is high.
Alcohol can also make drowsiness or mood effects harder to judge.
- Do not combine with MAO inhibitors, including within the 14-day window.
- Use caution with medicines that affect blood pressure or heart rate.
- Watch for psychiatric interactions if mood symptoms worsen.
- Be alert to liver-related issues if symptoms suggest hepatic problems.
- Report suspected adverse reactions through the MHRA Yellow Card scheme.
| Interaction Level | Examples | What To Do |
|---|---|---|
| Avoid | MAO inhibitors | Do not use together |
| Use Caution | Medicines affecting blood pressure or heart rate | Monitor pulse and blood pressure |
| Monitor | Alcohol, tea, and coffee if side effects worsen | Reduce if palpitations or sleep issues appear |
Liver enzyme abnormalities are a recognised concern, so any yellowing of the skin, dark urine, or persistent abdominal symptoms needs medical review.
That same common-sense approach applies to mood changes.
If a child or young person becomes withdrawn, unusually irritable, or more distressed, it should not be brushed off as “just the medicine wearing in”.
Cultural Perceptions And Patient Habits In The United Kingdom
What do UK patients usually say about Strattera on forums and in community pharmacy chats?
Slow onset comes up again and again.
So do dry mouth, reduced appetite, and the feeling that atomoxetine is less intense than stimulant medicine.
For some families, that is a positive.
For others, it feels frustrating because they want a more obvious effect.
Patient.info and Mumsnet-style discussions often focus on the same day-to-day issues rather than technical pharmacology.
- “It is taking longer than I expected to work.”
- “The appetite change was the first thing we noticed.”
- “Dry mouth is annoying but manageable.”
- “It feels steadier than stimulant treatment.”
- “We needed a proper pharmacist explanation before changing brands.”
That trust in pharmacists is very British, and it matters in community settings.
People ring NHS 111, check patient portals, and rely on repeat prescription reminders because ADHD treatment works best when the practical details are clear.
Atomoxetine’s non-controlled status is another reason some patients prefer it, especially when they want a medicine that is less likely to raise concerns around misuse.
Availability And Pricing Patterns: NHS, Private, And Online Access
How easy is it to get Strattera in the UK?
Access is usually through the NHS, private clinics, or regulated online pharmacy fulfilment.
Strattera price varies by route, strength, and regional prescription rules across England, Scotland, Wales, and Northern Ireland.
In England, prescription charges can differ from the devolved nations, where supply arrangements are not identical.
Searches such as “Buy Strattera online” usually lead to regulated services rather than direct retail sale, because it is prescription only.
In our online pharmacy, strattera is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.
| Access Route | Typical Features | Practical Note |
|---|---|---|
| NHS prescription | Clinical review, repeat prescription systems, standard safety monitoring | Usual route for ongoing ADHD treatment |
| Private purchase | Specialist assessment and separate payment | Can be quicker for some patients |
| Online pharmacy fulfilment | Convenient ordering and home delivery | Must still be regulated and prescription-led |
After patent expiry, multiple manufacturers may supply atomoxetine generic ADHD capsules, which can improve availability but also change the appearance of the medicine from one month to the next.
That is why patients should check the label rather than relying only on capsule colour.
Comparable Medicines And Preferences: What NHS Prescribers Consider
How does atomoxetine compare with the better-known ADHD medicines?
Prescribers usually balance speed, tolerability, and misuse risk.
Stimulants often work faster, but atomoxetine can be the better fit when a non-stimulant is preferred or needed.
| Medicine | Type | Typical Reason It May Be Chosen |
|---|---|---|
| Ritalin | Stimulant | Fast symptom control |
| Concerta | Stimulant | Extended-release stimulant option |
| Vyvanse | Stimulant | Another stimulant choice for ADHD |
| Intuniv | Non-stimulant | Alternative non-stimulant option |
| Kapvay | Non-stimulant adjunct | Adjunct treatment in some cases |
| Atomoxetine | Non-stimulant | When stimulants are unsuitable, ineffective, or poorly tolerated |
- Pros: Not a controlled substance, lower abuse potential, useful when stimulants are not suitable.
- Cons: Slower onset, gradual titration, and need for early monitoring of mood and cardiovascular effects.
- Best fit: Patients who want a non-stimulant ADHD medication and can wait for steady benefit.
Brand versus generic can affect price and supply, but not the active ingredient.
So if a GP or specialist switches a patient from Strattera to generic atomoxetine, the treatment aim stays the same.
Frequently Asked Questions About Strattera
- How Long Does Strattera Take To Work?
- It usually needs several weeks, and treatment is commonly reviewed after a minimum 4 to 6 week trial before benefit is judged properly.
- What Should I Do If I Miss A Dose?
- Take it as soon as you remember, unless it is close to the next dose. In that case, skip it and do not double up.
- Can Strattera Be Taken With Food?
- Yes, it can be taken as directed with or without food, although some people find food helps if nausea or stomach upset is a problem.
- Is Strattera Addictive Or A Controlled Drug?
- No. It is prescription only, but it is not a controlled substance, which is one reason some patients prefer it over stimulant treatment.
- What If Side Effects Become Troublesome?
- Contact the GP, specialist, or pharmacist if side effects are persistent, worsening, or linked with mood changes, palpitations, or liver concerns.
Guidelines For Proper Use: Pharmacist Counselling And NHS Support
What should a patient actually do day to day on Strattera capsules?
Start with the prescribed dose, stick to the schedule, and keep the follow-up plans.
That sounds simple, but it is where a lot of ADHD treatment either succeeds or falls apart.
- Take atomoxetine exactly as prescribed and do not change the dose on your own.
- Do not double a missed dose.
- Store capsules at 15–25°C, away from moisture and light, and keep them out of reach of children.
- Keep the original packaging for transport and identification.
- Seek urgent medical help for overdose symptoms such as somnolence, hyperactivity, stomach upset, or abnormal behaviour.
- Contact the GP or specialist promptly if mood changes, suicidal thoughts, palpitations, or blood pressure concerns appear.
- Check patient apps, electronic records, or repeat prescription instructions so the dose matches the current plan.
Good UK pharmacy counselling usually covers what to expect in the first few weeks, how side effects may settle, and when the medicine should be reviewed.
That practical support can make the difference between stopping too early and giving the treatment a fair chance.
Long-term use is common when the medicine is helping and the monitoring stays sensible.
Delivery Across United Kingdom
| City | Region | Delivery time |
|---|---|---|
| London | Greater London | 5-7 days |
| Birmingham | West Midlands | 5-7 days |
| Manchester | North West England | 5-7 days |
| Glasgow | Scotland | 5-7 days |
| Edinburgh | Scotland | 5-7 days |
| Liverpool | North West England | 5-7 days |
| Leeds | West Yorkshire | 5-7 days |
| Sheffield | South Yorkshire | 5-9 days |
| Bristol | South West England | 5-7 days |
| Newcastle upon Tyne | North East England | 5-7 days |
| Nottingham | East Midlands | 5-9 days |
| Cardiff | Wales | 5-7 days |
| Belfast | Northern Ireland | 5-7 days |
| Coventry | West Midlands | 5-9 days |